Clinical Trials Logo

Clinical Trial Summary

To enhance the oral bioavailability of the antioxidants trans-resveratrol and trans-ε-viniferin from Vineatrol30 grapevine-shoot extract, the native powder was incorporated into micelles. A single dose, single blind, two arms crossover trial was conducted. Plasma and urine samples were collected at intervals up to 24 h after oral intake of native or micellar Vineatrol30 (500 mg), and resveratrol content was quantified and compared between formulations. Tolerability of the dose was also controlled by safety parameters in plasma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02944097
Study type Interventional
Source University of Hohenheim
Contact
Status Completed
Phase Early Phase 1
Start date March 2015
Completion date February 2017

See also
  Status Clinical Trial Phase
Completed NCT03530436 - Comparison of Curcumin Bioavailability N/A
Completed NCT03140397 - Oral Bioavailability and Bioactivity of Prenylflavonoids From Hops Early Phase 1
Completed NCT02944084 - Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract Early Phase 1